For: | Shi YJ, Dong GJ, Guo M. Targeting epicardial adipose tissue: A potential therapeutic strategy for heart failure with preserved ejection fraction with type 2 diabetes mellitus. World J Diabetes 2023; 14(6): 724-740 [PMID: 37383601 DOI: 10.4239/wjd.v14.i6.724] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v14/i6/724.htm |
Number | Citing Articles |
1 |
Tian-Yu Wang, Qiang Yang, Xin-Yi Cheng, Jun-Can Ding, Peng-Fei Hu. Beyond weight loss: the potential of glucagon-like peptide-1 receptor agonists for treating heart failure with preserved ejection fraction. Heart Failure Reviews 2024; 30(1): 17 doi: 10.1007/s10741-024-10438-2
|
2 |
Jacob Whitman, Elie Kozaily, Erin D. Michos, Daniel N. Silverman, Marat Fudim, Robert J. Mentz, Ryan J. Tedford, Vishal N. Rao. Epicardial Fat in Heart Failure and Preserved Ejection Fraction: Novel Insights and Future Perspectives. Current Heart Failure Reports 2025; 22(1) doi: 10.1007/s11897-025-00700-5
|
3 |
Nassiba Menghoum, Maria Chiara Badii, Martin Leroy, Marie Parra, Clotilde Roy, Sibille Lejeune, David Vancraeynest, Agnes Pasquet, Dulce Brito, Barbara Casadei, Christophe Depoix, Gerasimos Filippatos, Damien Gruson, Frank Edelmann, Vanessa M. Ferreira, Renaud Lhommel, Masliza Mahmod, Stefan Neubauer, Alexandre Persu, Stefan Piechnik, Kristian Hellenkamp, Ignatios Ikonomidis, Bartosz Krakowiak, Burkert Pieske, Elisabeth Pieske-Kraigher, Fausto Pinto, Piotr Ponikowski, Michele Senni, Jean-Noël Trochu, Nancy Van Overstraeten, Rolf Wachter, Bernhard L. Gerber, Jean-Luc Balligand, Christophe Beauloye, Anne-Catherine Pouleur. Exploring the impact of metabolic comorbidities on epicardial adipose tissue in heart failure with preserved ejection fraction. Cardiovascular Diabetology 2025; 24(1) doi: 10.1186/s12933-025-02688-7
|
4 |
Zhongwen Qi, Dan Wu, Zhipeng Yan, Qing Wang, Yiming Li, Junnan Zhao, Fengqin Xu. Role of epicardial adipose tissue in heart failure with preserved ejection fraction: An emerging molecular mechanism and therapeutic potential. Obesity Reviews 2025; doi: 10.1111/obr.13912
|
5 |
Ruijue Huang, Wenjia Li, Zhen Xie, Kaimin Zhuo, Jing Zhu. Epicardial Adipose Tissue and Major Adverse Cardiovascular Events in Myocardial Infarction Patients with and without Diabetes. Academic Radiology 2024; 31(9): 3546 doi: 10.1016/j.acra.2024.04.001
|
6 |
Paolo Raggi, Arthur E. Stillman. Clinical Role of Epicardial Adipose Tissue. Canadian Journal of Cardiology 2025; doi: 10.1016/j.cjca.2025.02.021
|
7 |
Lingyun Luo, Yuyue Zuo, Lei Dai. Metabolic rewiring and inter-organ crosstalk in diabetic HFpEF. Cardiovascular Diabetology 2025; 24(1) doi: 10.1186/s12933-025-02707-7
|
8 |
Qiuxuan Li, Ur Rehman Muhib, Xiaoteng Ma, Zaiqiang Liu, Fei Gao, Zhijian Wang. Potential Mechanisms of Epicardial Adipose Tissue Influencing Heart Failure with Preserved Ejection Fraction. Reviews in Cardiovascular Medicine 2024; 25(9) doi: 10.31083/j.rcm2509311
|
9 |
Yuanwei Xu, Jiajun Guo, Yangjie Li, Shiqian Wang, Ke Wan, Weihao Li, Jie Wang, Ziqian Xu, Wei Cheng, Jiayu Sun, Qing Zhang, Yuchi Han, Yucheng Chen. Increased epicardial adipose tissue is associated with left ventricular reverse remodeling in dilated cardiomyopathy. Cardiovascular Diabetology 2024; 23(1) doi: 10.1186/s12933-024-02517-3
|
10 |
Martina Vincenzi, Canan G. Nebigil. Uncovering the role of prokineticin pathway on Epicardial Adipose Tissue (EAT) development and EAT-associated cardiomyopathy. Trends in Cardiovascular Medicine 2025; doi: 10.1016/j.tcm.2025.02.006
|
11 |
Julita Tokarek, Emilian Budny, Maciej Saar, Kamila Stańczak, Ewa Wojtanowska, Ewelina Młynarska, Jacek Rysz, Beata Franczyk. Molecular Processes Involved in the Shared Pathways between Cardiovascular Diseases and Diabetes. Biomedicines 2023; 11(10): 2611 doi: 10.3390/biomedicines11102611
|
12 |
O. V. Tsygankova, N. E. Apartseva, L. D. Latyntseva, A. N. Ryabikov. Extended-release metformin in patients with prediabetes, chronic heart failure and abdominal obesity in light of the effect on fat depot compartments and glucose metabolism parameters. Diabetes mellitus 2024; 27(4): 357 doi: 10.14341/DM13189
|
13 |
O. V. Tsygankova, N. E. Apartseva, L. D. Latyntseva, A. N. Ryabikov, E. V. Kashtanova. Long-term effects of metformin on fat depots and insulin-glucose parameters in patients with prediabetes and chronic heart failure. Meditsinskiy sovet = Medical Council 2024; (16): 274 doi: 10.21518/ms2024-347
|